New Vernon Capital Holdings Ii LLC Catalyst Pharmaceuticals, Inc. Transaction History
New Vernon Capital Holdings Ii LLC
- $208 Billion
- Q2 2025
A detailed history of New Vernon Capital Holdings Ii LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, New Vernon Capital Holdings Ii LLC holds 13,520 shares of CPRX stock, worth $278,376. This represents 0.14% of its overall portfolio holdings.
Number of Shares
13,520
Previous 327,860
95.88%
Holding current value
$278,376
Previous $13.5 Million
2070.0%
% of portfolio
0.14%
Previous 0.31%
Shares
4 transactions
Others Institutions Holding CPRX
# of Institutions
385Shares Held
103MCall Options Held
0Put Options Held
277K-
Black Rock Inc. New York, NY18.7MShares$385 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$180 Million0.0% of portfolio
-
State Street Corp Boston, MA5.48MShares$113 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$66.9 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$65.5 Million0.0% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.12B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...